Rifat Mahfuza, Milton Abul Hasnat, Hall John, Oldmeadow Christopher, Islam Md Akramul, Husain Ashaque, Akhanda Md Wahiduzzaman, Siddiquea Bodrun Naher
The University of Newcastle, Newcastle, New South Wales, Australia; BRAC, Dhaka, Bangladesh.
The University of Newcastle, Newcastle, New South Wales, Australia.
PLoS One. 2014 Aug 19;9(8):e105214. doi: 10.1371/journal.pone.0105214. eCollection 2014.
To determine the risk factors for developing multidrug resistant tuberculosis in Bangladesh.
This case-control study was set in central, district and sub-district level hospitals of rural and urban Bangladesh. Included were 250 multidrug resistant tuberculosis (MDR-TB) patients as cases and 750 drug susceptible tuberculosis patients as controls. We recruited cases from all three government hospitals treating MDR-TB in Bangladesh during the study period. Controls were selected randomly from those local treatment units that had referred the cases. Information was collected through face-to-face interviews and record reviews. Unadjusted and multivariable logistic regression were used to analyse the data.
Previous treatment history was shown to be the major contributing factor to MDR-TB in univariate analysis. After adjusting for other factors in multivariable analysis, age group "18-25" (OR 1.77, CI 1.07-2.93) and "26-45" (OR 1.72, CI 1.12-2.66), some level of education (OR 1.94, CI 1.32-2.85), service and business as occupation (OR 2.88, CI 1.29-6.44; OR 3.71, CI 1.59-8.66, respectively), smoking history (OR 1.58, CI 0.99-2.5), and type 2 diabetes (OR 2.56 CI 1.51-4.34) were associated with MDR-TB. Previous treatment was not included in the multivariable analysis as it was correlated with multiple predictors.
Previous tuberculosis treatment was found to be the major risk factor for MDR-TB. This study also identified age 18 to 45 years, some education up to secondary level, service and business as occupation, past smoking status, and type 2 diabetes as comorbid illness as risk factors. National Tuberculosis programme should address these risk factors in MDR-TB control strategy. The integration of MDR-TB control activities with diabetes and tobacco control programmes is needed in Bangladesh.
确定孟加拉国耐多药结核病发生的风险因素。
本病例对照研究在孟加拉国城乡的中心、区级和县级医院开展。纳入250例耐多药结核病(MDR-TB)患者作为病例组,750例药物敏感结核病患者作为对照组。研究期间,我们从孟加拉国所有三家治疗耐多药结核病的政府医院招募病例。对照组从转诊这些病例的当地治疗单位中随机选取。通过面对面访谈和记录审查收集信息。采用未调整和多变量逻辑回归分析数据。
单因素分析显示,既往治疗史是耐多药结核病的主要促成因素。多变量分析在调整其他因素后,年龄组“18 - 25岁”(比值比[OR] 1.77,可信区间[CI] 1.07 - 2.93)和“26 - 45岁”(OR 1.72,CI 1.12 - 2.66)、一定程度的教育水平(OR 1.94,CI 1.32 - 2.85)、从事服务业和商业(OR分别为2.88,CI 1.29 - 6.44;OR 3.71,CI 1.59 - 8.66)、吸烟史(OR 1.58,CI 0.99 - 2.5)以及2型糖尿病(OR 2.56,CI 1.51 - 4.34)与耐多药结核病相关。既往治疗未纳入多变量分析,因为它与多个预测因素相关。
既往结核病治疗被发现是耐多药结核病的主要风险因素。本研究还确定18至45岁、中学及以下一定教育水平、从事服务业和商业、既往吸烟状况以及2型糖尿病作为合并症为风险因素。国家结核病规划应在耐多药结核病控制策略中应对这些风险因素。孟加拉国需要将耐多药结核病控制活动与糖尿病和烟草控制项目相结合。